The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and EstoniaMartí Català, Annika M. Jödicke, Núria Mercadé‐Besora et al.|The Lancet Respiratory Medicine|2024Cited by 166
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Anthony G. Sena et al.|Lara D. Veeken|2021Cited by 53
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complicationsNúria Mercadé‐Besora, Martí Català, Xintong Li et al.|Heart|2024Cited by 50
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular OutcomesRohan Khera, Patrick B. Ryan, Arya Aminorroaya et al.|Journal of the American College of Cardiology|2024Cited by 33
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Marc A. Suchard, Lovedeep Singh Dhingra et al.|BMJ Medicine|2023Cited by 27